Skip to contentClarengateINTELLIGENCE
Companies/10942620

Swanbio Therapeutics Limited

Research and experimental development on biotechnology · Stevenage

ActiveUnited KingdomIncorporated 2017Private Limited Company
Register Ask analyst

Financial position

Accounts to 2021-09-30 · GBP

Net assets
£1,365,849
Cash
—
Turnover
—
Profit / loss
—
Current assets
£13,481,467
Creditors < 1 year
£12,115,618
Equity
£1,365,849
Average employees
6

Balance-sheet trend

GBP · unknown

Two periods with a known, matching scope are needed for a trend.

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

4 periods
Reported figures2021-09-3012 months2020-09-3012 months2019-09-3012 months2018-09-3013 months
Balance sheet
Net assets£1,365,849£9,180,713£11,363,643£3,539,269
Equity£1,365,849£9,180,713£11,363,643£3,539,269
Assets
Fixed assets——£0—
Current assets£13,481,467£12,138,285£12,664,450£4,040,631
Liabilities
Creditors within one year£12,115,618£2,957,572£1,300,807£617,361
Net current assets£1,365,849£9,180,713£11,363,643£3,539,269
Assets less current liabilities£1,365,849£9,180,713£11,363,643£3,539,269
People & pay
Average employees6422
Source evidenceView filing View filing View filing View filing

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

0 outstanding charges

No charges available in our records.